118 related articles for article (PubMed ID: 2401748)
1. Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography.
Soons PA; Kroon JM; Breimer DD
J Clin Pharmacol; 1990 Aug; 30(8):693-8. PubMed ID: 2401748
[TBL] [Abstract][Full Text] [Related]
2. Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.
Bauer LA; Murray K; Horn JR; Opheim K; Olsen J
Eur J Clin Pharmacol; 1989; 37(3):257-60. PubMed ID: 2612540
[TBL] [Abstract][Full Text] [Related]
3. The influence of nifedipine and captopril on liver blood flow in healthy subjects.
Burggraaf J; Schoemaker RC; Kroon JM; Cohen AF
Br J Clin Pharmacol; 1998 May; 45(5):447-51. PubMed ID: 9643616
[TBL] [Abstract][Full Text] [Related]
4. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Ott P; Keiding S; Bass L
Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
[TBL] [Abstract][Full Text] [Related]
5. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
[TBL] [Abstract][Full Text] [Related]
6. Specific assay for the quantitation of indocyanine green in rat plasma using high-performance liquid chromatography with fluorescence detection.
Dorr MB; Pollack GM
J Pharm Sci; 1989 Apr; 78(4):328-33. PubMed ID: 2724097
[TBL] [Abstract][Full Text] [Related]
7. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
Soons PA; De Boer A; Cohen AF; Breimer DD
Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
[TBL] [Abstract][Full Text] [Related]
8. Experimental impact of assay-dependent differences in plasma indocyanine green concentration determinations.
Grasela DM; Rocci ML; Vlasses PH
J Pharmacokinet Biopharm; 1987 Dec; 15(6):601-13. PubMed ID: 3450844
[TBL] [Abstract][Full Text] [Related]
9. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L
Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687
[TBL] [Abstract][Full Text] [Related]
10. [The effect of the method of detecting indocyanine green (HPLC, spectrophotometry) on the determination of pharmacokinetic parameters].
Aubrecht J; Perlík F
Cesk Farm; 1990 Jun; 39(4):155-7. PubMed ID: 2393913
[TBL] [Abstract][Full Text] [Related]
11. [Evaluating liver functional reserve by combining D-sorbitol with indocyanine green measurement].
Gao WT; Li YM; Ji H; Yang WB
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):350-3. PubMed ID: 12837214
[TBL] [Abstract][Full Text] [Related]
12. [The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination].
Sigusch H; Henschel L; Hoffmann A
Gastroenterol J; 1991; 51(1):33-6. PubMed ID: 1910493
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bromosulphthalein and indocyanine green clearance in sheep.
West HJ
Res Vet Sci; 1995 Sep; 59(2):176-9. PubMed ID: 8525111
[TBL] [Abstract][Full Text] [Related]
14. No effect of diltiazem on the hepatic clearance of indocyanine green in the rats.
Joo EH; Lee YB
Arch Pharm Res; 1998 Aug; 21(4):411-7. PubMed ID: 9875468
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green clearance following single and chronic cimetidine doses.
MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
[TBL] [Abstract][Full Text] [Related]
16. Cerebral near infrared spectroscopy for the measurement of indocyanine green elimination in cirrhosis.
Therapondos G; Plevris JN; Stanley AJ; Peters CJ; Teig M; Hayes PC
Aliment Pharmacol Ther; 2000 Jul; 14(7):923-8. PubMed ID: 10886049
[TBL] [Abstract][Full Text] [Related]
17. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
[TBL] [Abstract][Full Text] [Related]
18. The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
van Harten J; van Brummelen P; Zeegers RR; Danhof M; Breimer DD
Br J Clin Pharmacol; 1988 Jun; 25(6):709-17. PubMed ID: 3203043
[TBL] [Abstract][Full Text] [Related]
19. Effects of diltiazem on the pharmacokinetics of nifedipine.
Ohashi K; Tateishi T; Sudo T; Sakamoto K; Toyosaki N; Hosoda S; Toyo-oka T; Sugimoto K; Kumagai Y; Ebihara A
J Cardiovasc Pharmacol; 1990 Jan; 15(1):96-101. PubMed ID: 1688989
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2-methylaminoethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2-carboxylic acid-2'-carboxylate monohydrochloride (DDB-S) on indocyanine green (ICG) clearance in rats.
Lee KJ; Kim JR; Lee CH
Arch Pharm Res; 2005 Jan; 28(1):115-9. PubMed ID: 15742819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
